Biochips Market

Biochips Market Size & Share by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), Fabrication Technology (Microarrays, Microfluidics), End user (Academics Institutes, Diagnostics Centers) - Global Forecast to 2020

Report Code: MD 4275 May, 2016, by marketsandmarkets.com

[170 Pages Report] The overall market size of biochips is estimated to grow at a CAGR of 18.4% from 2015 to 2020 to reach $17.75 billion by 2020. The base year considered for the study is 2015 and the forecast for the market size is provided for the period between 2015 and 2020. In the current market scenario, biochips are increasingly adopted in various applications in the field of genomics, drug discovery, and proteomics. In addition, the development of targeted and personalized medicines for the treatment of cancer and technological advancements in biochips are also supporting the growth of biochip products. The objective of Market report is to define, describe, and forecast the global market of biochips on the basis of type, applications, end user, and region. It provides detailed information regarding the major factors influencing the growth of overall market. Drivers, restraints, opportunities, challenges, and trends in the market have also been taken into consideration while preparing this report. This report also tracks and analyzes competitive developments of the key players in market in terms of market developments, product portfolios, and key financials.

Biochips Market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of various other dependent submarkets. The fabrication technology markets for all segments were determined through secondary research and were added up to obtain the global market value. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources we referred are U.S. Food and Drug Administration, Journal of Biochips & Tissue Chips, American Medical Association (AMA), National Cancer Institute, Journal of Molecular Diagnostic and The World Bank.

Biochips Market

To know about the assumptions considered for the study, download the pdf brochure

Target Audience:

  • Biochip manufacturers and distributors
  • Pharmaceutical companies
  • Biotechnology companies
  • Research institutes
  • Academic Institutes
  • Contract research organizations
  • Research and consulting companies

Scope of the Report

The research report categorizes the global biochips market into the following segments and subsegments:

By Type

  • DNA Chips Market, By Application

    • Gene Expression
    • SNP Genotyping
    • Cancer Diagnosis & Treatment
    • Genomics
    • Drug Discovery
    • Agricultural Biotechnology
    • Other DNA Chip Applications
  • Lab-On-A-Chip Market, By Applications

    • Clinical Diagnostics
    • Genomics
    • IVD & POC
    • Proteomics
    • Drug Discovery
    • Other Loac Applications Market
  • Protein Chips Market, By Applications

    • Proteomics
    • Expression Profiling
    • Diagnostics
    • High-Throughput Screening
    • Drug Discovery
    • Other Applications
  • Other Arrays, By Type

    • Cell Arrays
    • Tissue Arrays

By Fabrication Technology

  • Microarrays
  • Microfluidics

By End User

  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostics Centers
  • Academic & Research Institutes
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the global market into countries from North America, Europe, Asia and RoW

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

By technology the microfluidics segment is expected to be the faster growing in the biochips market during the forecast period.

The microfluidics segment is projected to grow at the highest CAGR between 2015 and 2020. The growing demand for POC diagnostic devices such as glucose monitoring and pregnancy test kits is driving the market growth in the microfluidics segment

By end user, the hospitals & diagnostic centers segment is growing at the highest rate.

The hospitals & diagnostic centers segment is projected to grow at the highest rate in the market, by end user. The increasing use of biochips in hospitals and diagnostic centers due to their advantages such as reduction of time and cost, ability to deliver high throughput without the need for heavy and bulky instruments is driving the market growth in this end-user segment

Biochips Market

North America is expected to account for the largest market share during the forecast period.

The biochips market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2015, North America is expected to account for the largest share of this market, followed by Europe. Factors such as increasing aging population and rising prevalence of lifestyle diseases and cardiac disorders are the key drivers for the growth of the North American biochips market
On the other hand, the market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Rapid growth in the life sciences industry in China and India, growth in biotechnology and pharmaceutical research, and low infrastructure costs are some major factors driving the growth of the biochips market in Asia

Key Market Players

Key players in the biochips market include Abbott Laboratories (US), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), Fluidigm Corporation (US), Illumina, Inc. (US), GE Healthcare (US), Bio-Rad Laboratories Inc. (US), Cepheid Inc. (US), Thermo Fisher Scientific, Inc. (US), and F. Hoffmann-La Roche AG (Switzerland).

Thermo Fisher Scientific is among the leaders in the biochips market, with a strong presence in different locations across the globe. The company marked its leadership position through the acquisition of Affymetrix Inc., the first company to commercialize DNA microarrays. Through this acquisition, Affymetrix added complementary products in genetic analysis, which are used in cytogenetics, genotyping, and gene expression, to the company’s life sciences portfolio. The US is the major market for the company and it generates a large part of its revenue from this market; for instance, in 2015, it generated around 50.7% of its revenue from the US

Recent Developments:

  • In 2016, Thermo Fisher Scientific Inc. completed the acquisition of Affymetrix Inc., a leading provider of cellular and genetic analysis products. This acquisition helped Thermo Fisher to strengthen its leadership in biosciences, as well as acquire new genetic analysis capabilities to better serve clinical and applied markets.
  • In 2015, Affymetrix (US) and Cytox (UK), an innovative developer of assays for risk assessment and prediction of dementia, formed a strategic partnership to develop and commercialize blood-based genetic assay for Alzheimer’s disease risk assessment. This partnership helped the company extend its offering to the dementia research market.

Key questions addressed by the report:

  • Who are the major market players in the biochips market?
  • What are the regional growth trends and the largest revenue-generating regions for biochips market?
  • What are the major drivers and challenges in the biochips market?
  • What are the major product segments in the biochipa market?
  • What are the major end users for biochips

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
           2.2.3 Key Industry Insights
           2.2.4 Assumptions

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 33)
    4.1 Market Overview
    4.2 Market: By Application and End User
    4.3 Market: Geographic Snapshot
    4.4 Market: By Type
    4.5 Market: By End User
    4.6 Market: By Fabrication Technology

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Type and Application
           5.2.2 By Fabrication Technology
           5.2.3 By End User
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Increasing Adoption of Personalized Medicine
                    5.3.1.2 Growing Applications of Biochips
                    5.3.1.3 Technological Advancements
           5.3.2 Restraints
                    5.3.2.1 Unclear Regulatory Guidelines
                    5.3.2.2 High Instrumentation Costs
                    5.3.2.3 Absolute Quantification of Specific Mrna Expressions
           5.3.3 Opportunities
                    5.3.3.1 Significant Growth Prospects in Developing Countries
                    5.3.3.2 Biochip Technology, A Safe and Economical Alternative to Animal Testing
           5.3.4 Challenges
                    5.3.4.1 Complexity of Biological Systems

6 By Type (Page No. - 50)
    6.1 Introduction
    6.2 DNA Chips
           6.2.1 DNA Chips Market, By Application
                    6.2.1.1 Gene Expression
                    6.2.1.2 SNP Genotyping
                    6.2.1.3 Cancer Diagnosis & Treatment
                    6.2.1.4 Genomics
                    6.2.1.5 Drug Discovery
                    6.2.1.6 Agricultural Biotechnology
                    6.2.1.7 Other DNA Chip Applications
    6.3 Lab-On-A-Chip
           6.3.1 Lab-On-A-Chip Market, By Application
                    6.3.1.1 Clinical Diagnostics
                    6.3.1.2 Genomics
                    6.3.1.3 IVD & POC
                    6.3.1.4 Proteomics
                    6.3.1.5 Drug Discovery
                    6.3.1.6 Other Loac Applications Market
    6.4 Protein Chips
           6.4.1 Protein Chips Market, By Applications
                    6.4.1.1 Proteomics
                    6.4.1.2 Expression Profiling
                    6.4.1.3 Diagnostics
                    6.4.1.4 High-Throughput Screening
                    6.4.1.5 Drug Discovery
                    6.4.1.6 Other Applications
    6.5 Other Arrays
           6.5.1 Cell Arrays
           6.5.2 Tissue Arrays

7 By Fabrication Technology (Page No. - 89)
    7.1 Introduction
    7.2 Microarrays
    7.3 Microfluidics

8 By End User (Page No. - 95)
    8.1 Introduction
    8.2 Biotechnology and Pharmaceutical Companies
    8.3 Hospitals and Diagnostics Centers
    8.4 Academic & Research Institutes
    8.5 Others

9 By Region (Page No. - 103)
    9.1 Introduction
    9.2 North America
    9.3 Europe
    9.4 Asia-Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 130)
     10.1 Overview
     10.2 Competitive Situation and Trends
             10.2.1 Agreements, Partnerships, and Collaborations
             10.2.2 Acquisitions
             10.2.3 Product Launches and Enhancements
             10.2.4 Expansions
             10.2.5 Other Developments

11 Company Profiles (Page No. - 138)
(Overview, Financial*, Products & Services, Strategy, and Developments)
     11.1 Introduction
     11.2 Abbott Laboratories
     11.3 Agilent Technologies, Inc.
     11.4 Perkinelmer, Inc.
     11.5 Fluidigm Corporation
     11.6 Illumina, Inc.
     11.7 GE Healthcare
     11.8 Bio-Rad Laboratories Inc.
     11.9 Cepheid Inc.
     11.10 Thermo Fisher Scientific, Inc.
     11.11 Roche Diagnostics

*Details Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 162)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports


List of Tables (76 Tables)

Table 1 Increasing Adoption of Personalized Medicine, A Key Driver for the Growth of the Market
Table 2 Regulatory Hurdles to Limit Global Market Growth During the Forecast Period
Table 3 Lucrative Opportunities in Developing Countries May Boost Market Growth
Table 4 Complexity of Biological Systems May Hamper the Growth of the Market
Table 5 Global Market Size of Biochips, By Type, 2013–2020 (USD Million)
Table 6 DNA Chips Market Size, By Region, 2013–2020 (USD Million)
Table 7 DNA Chips Market Size, By Application, 2013–2020 (USD Million)
Table 8 Gene Expression Market Size, By Region, 2013–2020 (USD Million)
Table 9 SNP Genotyping Market Size, By Region, 2013–2020 (USD Million)
Table 10 Cancer Diagnosis and Treatment Market Size, By Region,  2013–2020 (USD Million)
Table 11 Genomics Market Size, By Region, 2013–2020 (USD Million)
Table 12 Drug Discovery Market Size, By Region, 2013–2020 (USD Million)
Table 13 Agricultural Biotechnology Market Size, By Region, 2013–2020 (USD Million)
Table 14 Other DNA Chip Applications Market Size, By Region, 2013–2020 (USD Million)
Table 15 Lab-On-A-Chip Market Size, By Region, 2013–2020 (USD Million)
Table 16 Lab-On-A-Chip Market Size, By Application, 2013–2020 (USD Million)
Table 17 Clinical Diagnostics Market Size, By Region, 2013–2020 (USD Million)
Table 18 Genomics Market Size, By Region, 2013–2020 (USD Million)
Table 19 IVD and POC Market Size, By Region, 2013–2020 (USD Million)
Table 20 Proteomics Market Size, By Region, 2013–2020 (USD Million)
Table 21 Drug Discovery Market Size, By Region, 2013–2020 (USD Million)
Table 22 Other LOC Systems Market Size, By Region, 2013–2020 (USD Million)
Table 23 Protein Chips Market Size, By Application, 2013–2020 (USD Million)
Table 24 Protein Chips Market Size, By Region, 2013–2020 (USD Million)
Table 25 Proteomics Market Size, By Region, 2013–2020 (USD Million)
Table 26 Expression Profiling Market Size, By Region, 2013–2020 (USD Million)
Table 27 Diagnostics Market Size, By Region, 2013–2020 (USD Million)
Table 28 High-Throughput Screening Market Size, By Region, 2013–2020 (USD Million)
Table 29 Drug Discovery Market Size, By Region, 2013–2020 (USD Million)
Table 30 Other Protein Microarray Applications Market Size, By Region, 2013–2020 (USD Million)
Table 31 Other Arrays Market Size, By Type, 2013–2020 (USD Million)
Table 32 Other Arrays Market Size, By Region, 2013–2020 (USD Million)
Table 33 Cell Arrays Market Size, By Region, 2013–2020 (USD Million)
Table 34 Tissue Arrays Market Size, By Region, 2013–2020 (USD Million)
Table 35 Global Market Size, By Fabrication Technology, 2013–2020 (USD Million)
Table 36 Microarrays in global Market Size, By Region, 2013-2020 (USD Million)
Table 37 Microfluidics in global Market Size, By Region, 2013-2020 (USD Million)
Table 38 Global Market Size of Biochips, By End User, 2013–2020 (USD Million)
Table 39 Global Market Size of Biochips for Biotechnology and Pharmaceutical Companies, By Region, 2013–2020 (USD Million)
Table 40 Global Market Size of Biochips for Hospitals & Diagnostic Centers Market Size, By Region, 2013–2020 (USD Million)
Table 41 Global Market Size of Biochips for Academic & Research Institutes, By Region,  2013–2020 (USD Million)
Table 42 Global Market Size of Biochips for Other End Users, By Region, 2013–2020 (USD Million)
Table 43 Global Market Size of Biochips, By Region, 2013–2020 (USD Million)
Table 44 North America: Global Market Size of Biochips, By Type, 2013–2020 (USD Million)
Table 45 North America: Other Market Size of Biochips, By Type, 2013–2020 (USD Million)
Table 46 North America: DNA Chips Market Size, By Application,  2013–2020 (USD Million)
Table 47 North America: Lab-On-Chip Market Size, By Application,  2013–2020 (USD Million)
Table 48 North America: Protein Chips Market Size, By Application,  2013–2020 (USD Million)
Table 49 North America: Global Market Size of Biochips, By Fabrication Technology,  2013–2020 (USD Million)
Table 50 North America: Global Market Size of Biochips, By End User, 2013–2020 (USD Million)
Table 51 Europe: Global Market Size of Biochips, By Type, 2013–2020 (USD Million)
Table 52 Europe: Other Biochips Market Size, By Type, 2013–2020 (USD Million)
Table 53 Europe: DNA Chips Market Size, By Application, 2013–2020 (USD Million)
Table 54 Europe: Lab-On-Chip Market Size, By Application, 2013–2020 (USD Million)
Table 55 Europe: Protein Chips Market Size, By Application, 2013–2020 (USD Million)
Table 56 Europe: Market Size of Biochips, By Fabrication Technology,  2013–2020 (USD Million)
Table 57 Europe: Market Size of Biochips, By End User, 2013–2020 (USD Million)
Table 58 Asia-Pacific: Market Size of Biochips, By Type, 2013–2020 (USD Million)
Table 59 Asia-Pacific: Other Biochips Market Size, By Type, 2013–2020 (USD Million)
Table 60 Asia-Pacific: DNA Chips Market Size, By Application, 2013–2020 (USD Million)
Table 61 Asia-Pacific: Lab-On-Chip Market Size, By Application, 2013–2020 (USD Million)
Table 62 Asia-Pacific: Protein Chips Market Size, By Application,  2013–2020 (USD Million)
Table 63 Asia-Pacific: Market Size of Biochips, By Fabrication Technology,  2013–2020 (USD Million)
Table 64 Asia-Pacific: Market Size of Biochips, By End User, 2013–2020 (USD Million)
Table 65 RoW: Market Size of Biochips, By Type, 2013–2020 (USD Million)
Table 66 RoW: Other Biochips Market Size, By Type, 2013–2020 (USD Million)
Table 67 RoW: DNA Chips Market Size, By Application, 2013–2020 (USD Million)
Table 68 RoW: Lab-On-Chip Market Size, By Application, 2013–2020 (USD Million)
Table 69 RoW: Protein Chips Market Size, By Application, 2013–2020 (USD Million)
Table 70 RoW: Market Size of Biochips, By Fabrication Technology,  2013–2020 (USD Million)
Table 71 RoW: Market Size of Biochips, By End User, 2013–2020 (USD Million)
Table 72 Agreements, Partnerships, and Collaborations, 2013–2016
Table 73 Acquisitions, 2013-2015
Table 74 Product Launches and Enhancements, 2013–2015
Table 75 Expansions, 2013–2015
Table 76 Other Developments, 2013–2015


List of Figures (69 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation and Data Triangulation
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Country
Figure 4 Market Snapshot, 2015 vs 2020
Figure 5 DNA Chips Segment Will Continue to Dominate the Market in 2020
Figure 6 Microfluidics Segment to Witness the Highest Growth Rate in the Forecast Period
Figure 7 Hospitals and Diagnostics Centers Segment Dominated the Biochips End-User Market in 2015
Figure 8 Geographical Snapshot of the Market, 2015
Figure 9 Increased Adoption of Personalised Medicine to Drive the Market Growth During the Forecast Period
Figure 10 DNA Chips to Dominate the Global Market During the Forecast Period
Figure 11 Asia-Pacific to Register Highest Growth From 2015 to 2020
Figure 12 Lab-On-A-Chip Segment to Grow at the Highest Rate From 2015 to 2020
Figure 13 Hospitals & Diagnostic Centers to Dominate the Biochips End-User Market in 2015
Figure 14 High Growth Potential in the Microfluidics Fabrication Technology Market
Figure 15 Market Segmentation of Biochips, By Type and Application
Figure 16 Market Segmentation of Biochips, By Fabrication Technology
Figure 17 Market Segmentation of Biochips, By End User
Figure 18 Market of Biochips: Drivers, Restraints, Opportunities and Challenges
Figure 19 Oncology Treatment Options Market Share, 2003 vs 2013
Figure 20 Local vs Multinational Clinical Studies, 2015
Figure 21 DNA Biochips Accounted for the Largest Share of the Overall Market of Biochips, By Type, in 2015
Figure 22 Asia-Pacific to Grow at the Highest Rate in the Overall DNA Chips Market, By Region, During the Forecast Period
Figure 23 Cancer Diagnosis and Treatment Accounted for the Largest Share of DNA Chips Market, By Application, in 2015
Figure 24 Asia-Pacific is Expected to Register the Highest Growth Rate in the Gene Expression Market, By Region, During the Forecast Period
Figure 25 North America Accounted for the Largest Share of the SNP Genotyping Market During the Forecast Period
Figure 26 Asia-Pacific is Expected to Account for Highest Growth Rate of the Cancer Diagnosis and Treatment Market, By Region, During the Forecast Period
Figure 27 North America Accounted for the Largest Share of the Genomics Market, By Type, in 2015
Figure 28 Asia-Pacific to Grow at the Highest Rate in the Drug Discovery Market, By Region, During the Forecast Period
Figure 29 North America Accounted for the Largest Share of the Agriculture Biotechnology Market, By Application, During the Forecast Period
Figure 30 Clinical Diagnostics Accounted for the Largest Share of the Lab-On-A-Chip Market, By Application, in 2015
Figure 31 Asia-Pacific to Grow at the Highest Rate in the Clinical Diagnostics Market, By Region, During the Forecast Period
Figure 32 North America Accounted for the Largest Share of the Genomics Market, By Region, in 2015
Figure 33 Asia-Pacific to Register Highest Growth in the IVD and POC Market, By Region During the Forecast Period
Figure 34 North America Accounted for the Largest Share of the Proteomics Market, By Region, in 2015
Figure 35 Asia-Pacific to Grow at the Highest Rate in the Drug Discovery Market, By Region During the Forecast Period
Figure 36 Proteomics Accounted for the Largest Share of the Protein Chips Market, By Application, in 2015
Figure 37 North America Accounted for the Largest Share of the Proteomics Market, By Region, in 2015
Figure 38 Asia-Pacific to Grow at the Highest Rate in the Expression Profiling Market During the Forecast Period
Figure 39 North America Accounted for the Largest Share of the Diagnostics Market, By Region, in 2015
Figure 40 Asia-Pacific Market Will Register the Fastest Growth in the HTS Market During the Forecast Period
Figure 41 North America Accounted for the Largest Share of the Drug Discovery Market, By Region, in 2015
Figure 42 Tissue Arrays Accounted for the Largest Share of the Overall Other Arrays Market, By Type, in 2015
Figure 43 Asia-Pacific to Grow at the Highest Rate in the Other Arrays Market During the Forecast Period
Figure 44 Microarrays Will Continue to Dominate the Market in 2020
Figure 45 North America Accounted for the Largest Share of Microarrays Market in 2015
Figure 46 Asia-Pacific to Witness Highest Growth in Microfluidics in Market
Figure 47 Hospitals and Diagnostic Centers are the Major End Users of the Market During the Forecast Period
Figure 48 North America Will Continue to Dominate the Market for Biotechnology and Pharmaceutical Companies During the Forecast Period
Figure 49 Asia-Pacific Offers Lucrative Growth Opportunities for Market for Hospitals and Diagnostics Centers During the Forecast Period
Figure 50 North America Accounted for the Largest Share of the Other End Users Market in 2015
Figure 51 Geographic Snapshot: Asia-Pacific Will Be the Fastest-Growing Region in the Market By 2020
Figure 52 Asia-Pacific Market for Biochips Shows Significant Growth Opportunities
Figure 53 North America Will Continue to Lead the Global Market During the Forecast Period
Figure 54 North America: Market Snapshot 2015-2020
Figure 55 Gene Expression Segment to Show Highest Growth in the North American DNA Chips Market During the Forecast Period
Figure 56 Proteomics Will Continue to Lead the North American Protein Chips Market During the Forecast Period
Figure 57 Hospital and Diagnostics Centers Segment to Grow at the Highest CAGR During the Forecast Period
Figure 58 DNA Chips Will Continue to Dominate the European Market During the Forecast Period
Figure 59 Gene Expression Application Segment of the European DNA Chips Market is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 60 Hospital and Diagnostics Centers End-User Segment Will Continue to Dominate the European Market During the Forecast Period
Figure 61 Asia-Pacific Market Snapshot 2015-2020
Figure 62 Gene Expression Segment Will Continue to Lead the Asia-Pacific DNA Chips Market During the Forecast Period
Figure 63 Proteomics Holds Highest Share in the Asia-Pacific Protein Chips Market in 2015
Figure 64 Hospital and Diagnostics Centers Segment to Grow at the Highest CAGR During the Forecast Period
Figure 65 DNA Chips Will Continue to Hold the Highest Share in the RoW Market During the Forecast Period
Figure 66 Hospital and Diagnostics Centers Will Continue to Lead the Global Market During the Forecast Period
Figure 67 Acquisitions & Agreements, Collaborations, and Partnerships Were the Key Growth Strategies Adopted By Market Players Between  2013-2016
Figure 68 Acquisitions & Agreements, Collaborations, and Partnerships—Key Growth Strategies Adopted By Players in Market
Figure 69 Geographic Revenue Mix of the Top 5 Market Players


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 4275
Published ON
May, 2016
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biochips Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved